
The article outlines two options strategies for Legend Biotech Corp (LEGN) designed for yield enhancement or discounted share acquisition. Selling a $30.00 strike put, 12% out-of-the-money, offers a potential 10.00% return (15.53% annualized) if it expires worthless (71% probability), effectively targeting a $27.00 acquisition cost. Alternatively, a covered call at the $35.00 strike, 3% out-of-the-money, could yield a 14.91% total return if the stock is called away by May 2026, or an 11.79% (18.31% annualized) premium boost if it expires worthless (42% probability), leveraging LEGN's implied volatilities of 52-56% against a 49% trailing volatility.
The current options market for Legend Biotech Corp (LEGN) presents two distinct strategies for investors, centered on income generation and discounted share acquisition. The first strategy involves selling a May 2026 cash-secured put at a $30.00 strike price, which is approximately 12% out-of-the-money relative to the current share price of $33.94. This approach targets an effective acquisition cost of $27.00 per share if assigned, or generates a 10.00% return on cash (15.53% annualized) if the option expires worthless, an event with a stated 71% probability. The second strategy is a covered call, involving the sale of a $35.00 strike call for the same expiration. This yields a potential total return of 14.91% if the stock is called away, or an 11.79% premium boost (18.31% annualized) if it expires worthless, which has a 42% probability. A key consideration is the elevated implied volatility in both the put (52%) and call (56%) contracts relative to the stock's 49% trailing twelve-month historical volatility, suggesting that option sellers are currently being compensated with higher-than-average premiums.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.40
Ticker Sentiment